The Japan study of treatment for acute kidney injury in post-cardiovascular surgery patients by atrial natriuretic peptide

The Japan study of treatment for acute kidney injury in post-cardiovascular surgery patients by atrial natriuretic peptide - JAPAN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006812

Enrollment

200

Registered

2011-12-01

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular surgery-associated acute kidney injury

Interventions

carperitide (atrial natriuretic peptide) 5% glucose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Randamization of the cardiovascular surgery patients associated with acute kidney injury

Exclusion criteria

Exclusion criteria: 1) hypotension 2) right ventricular myocardial infarction 3) dehydration 4) patients with chronic kidney disease on hemodialysis 5) patients on percutaneous cardio-pulmonary support (PCPS)

Design outcomes

Primary

Measure	Time frame
Renal function, rate and duration of renal replacement therapy 3 months after administration of atrial natriuretic peptide	—

Secondary

Measure	Time frame
Days of ICU stay and hospital stay and medical costs 3 months after administration of atrial natriuretic peptide	—

Countries

Japan

Contacts

Public ContactChieko Mitaka

Tokyo Medical and Dental University Hospital of Medicine Intensive Care Unit

c.mitaka.icu@tmd.ac.jp03-5803-5653

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026